Skip to main content

Table 8 Comparison of length of hospital stay in the Modified ITT and perprotocol populations

From: The efficacy of corticosteroids therapy in patients with moderate to severe SARS-CoV-2 infection: a multicenter, randomized, open-label trial

 

Treatment groups

N

Length of stay in days

P-value

Mean

SD

Range

Modified ITT

Steroid + Azithromycin

89

5.5

3.1

1–19

0.028

Azithromycin

90

6.4

4.0

1–28

0.993

Lopinavir/Ritonavir

89

6.4

3.2

1–20

 

per-protocol

Steroid + Azithromycin

48

4.4

1.9

1–10

0.0007

Azithromycin

43

5.9

4.2

1–28

0.595

Lopinavir/Ritonavir

41

5.8

2.0

1–10

Â